×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Span Divergent Limited | NA | NA | NA | NA | 12.7 | 15.9 |
| DECIPHER LABS LIMITED | NA | NA | NA | NA | 11.4 | |
| DR LALCHANDANI LABS LIMITED | NA | NA | NA | NA | 11.3 | 26.8 |
Span Divergent Limited, with Security Code 524727, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.3 |
| Expenses | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 |
| Operating Profit | 0.1 | 0.2 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.2 | 0.0 | 0.0 |
| OPM % | 22.03% | 34.33% | 9.58% | 20.75% | 13.79% | 19.57% | -6.29% | 30.21% | 10.6% | -5.56% |
| Other Income | -0.9 | 0.2 | -2.8 | 0.2 | 0.2 | 0.2 | 1.0 | 0.2 | 0.3 | 0.3 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Profit before tax | 0.2 | 0.3 | 0.1 | 0.2 | 0.2 | 0.2 | 0.8 | 0.3 | 0.2 | 0.2 |
| Tax % | 1% | -5% | 0.4% | 19.4% | -6.8% | -7.2% | -2.5% | -31.1% | -2.4% | -8.6% |
| Net Profit | -0.9 | 0.3 | -2.9 | 0.3 | 0.2 | 0.2 | 0.9 | 0.2 | 0.2 | 0.2 |
| EPS in Rs | -1.63 | 0.49 | -5.34 | 0.51 | 0.3 | 0.36 | 1.6 | 0.42 | 0.44 | 0.43 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.1 | 3.3 | 3.4 | 3.4 | 2.9 | 3.0 | 3.0 | 3.7 | 2.8 | 1.9 |
| Expenses | 3.0 | 3.0 | 3.5 | 2.9 | 3.0 | 2.6 | 2.8 | 3.4 | 2.6 | 2.1 |
| Operating Profit | 0.1 | 0.3 | -0.1 | 0.6 | -0.1 | 0.4 | 0.2 | 0.3 | 0.2 | -0.2 |
| OPM % | 2.32% | 9.58% | -3.4% | 16.5% | -4.19% | 13.69% | 6.62% | 7.3% | 8.8% | -11.34% |
| Other Income | -0.9 | 0.2 | -2.8 | 0.2 | 0.6 | 0.4 | 1.0 | 0.2 | 0.2 | 0.5 |
| Interest | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
| Depreciation | 0.5 | 0.6 | 0.5 | 0.5 | 0.5 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Profit before tax | -0.5 | -0.3 | -0.6 | 0.1 | -0.2 | 0.2 | 0.6 | 0.0 | 0.1 | -0.2 |
| Tax % | -1.3% | -4.5% | -0.6% | 114.8% | 73.4% | -73.8% | 33.7% | -486.4% | -17.5% | 20.6% |
| Net Profit | -1.6 | -0.3 | -3.6 | 0.1 | -0.3 | 0.1 | 0.9 | -0.1 | 0.0 | -0.2 |
| EPS in Rs | -2.91 | -0.47 | -6.61 | 0.24 | -0.55 | 0.12 | 1.62 | -0.16 | 0.09 | -0.39 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -32% |
| 5 Years: | -1% |
| 3 Years: | -6% |
| TTM: | -16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 26% |
| 3 Years: | -4% |
| TTM: | 80% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | 19% |
| 3 Years: | 13% |
| 1 Year: | 5% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -19% |
| 5 Years: | -1% |
| 3 Years: | -12% |
| TTM: | -27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 13% |
| 3 Years: | 10% |
| TTM: | -1693% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | 19% |
| 3 Years: | 13% |
| 1 Year: | 5% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|